Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Recurrence × Quality Assurance, Health Care × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Recurrence 1 Neoplasms 1 Death 1

Interventions

Dexamethasone 14 Rituximab 6 venetoclax 4 Lenalidomide 4 Cytarabine 4 Bortezomib 4 Bendamustine Hydrochloride 4 selinexor 3 pomalidomide 3 pembrolizumab 3 ibrutinib 3 carfilzomib 3 Paclitaxel 3 Gemcitabine 3 Drug Therapy 3 Cyclophosphamide 3 Calcium Dobesilate 3 ixazomib 2 gilteritinib 2 fludarabine phosphate 2 fludarabine 2 elotuzumab 2 daratumumab 2 belinostat 2 Tablets 2 Surveys and Questionnaires 2 Panobinostat 2 Oxaliplatin 2 Etoposide 2 Cetuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07484282 2026-04-03

Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer

National Institutes of Health Clinical Center (CC)

Death, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡